Downloads

Understanding drug targets - there's no such thing as bad news


Download Type: Adobe PDF

Conducting comprehensive target safety reviews early in the drug discovery process enables project teams to make the right decisions aboutwhich drug targets to take forward.

How can small-to-medium pharma and biotech companies enhance the chances of running a successful drug project and maximise the return on a limited number of assets? Having a full appreciation of the safety risks associated with proposed drug targets is a crucial element in understanding the unwanted side-effects that might stop a project in its tracks. Having this information is necessary to complement

knowledge about the probable efficacy of a future drug. However, the lack of data-rich insight into drug target safety is one of the major causes of drug-project failure today. Conducting comprehensive target safety reviews early in the drug discovery process enables project teams to make the right decisions aboutwhich drug targets to take forward.

Share this download

More services